Instant coffee and powdered milk are produced by spray drying. Fraunhofer researchers have adapted this technique to the tricky question of incorporating insoluble substances in core-shell particles. The new method helps reduce the concentration of active ingredients in therapeutic medications.
Encapsulation is used in cosmetics and pharmaceuticals to protect active ingredients against external influences such as aggressive gastric acid. Another use of encapsulation is to control the release of active ingredients inside the body: depending on the permeability of the shell material, the medication is delivered gradually rather than all at once. Because such systems release multiple, smaller doses over an extended period of time, the drug therapy is better tolerated and easier to administer. In some cases, it means taking just one pill a day instead of three.
Insoluble substances are a problem
The first step of the encapsulation process involves dissolving the active ingredient in a liquid medium and mixing it with the shell material. Then the solution is piped to an orifice in the center of a nozzle surrounded by an annular channel through which compressed air is injected at high speed. The pressure disperses the solution into an aerosol of fine droplets, which is then sprayed into a drying cylinder. Here, the liquid evaporates, leaving behind a fine powder of core-shell particles. The problem is that it is difficult to mix insoluble substances with other materials. This limits the choice of shell materials that can be used to produce the particles.
Three-way nozzle permits endless combinations of materials
“For this reason, we use a three-way nozzle to implement spraying. Its advantage is that it permits two substances to be fed separately to the nozzle. The shear forces mix the substances together at the orifice of the nozzle, creating an aerosol containing both materials,” explains Michael Walz, who developed and optimized the new technique with his colleague Dr. Achim Weber at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart.
This system permits endless combinations of materials, enabling the controlled release of active ingredients to be adapted to different applications. “We can modify the particle size and encapsulation efficiency by selecting the appropriate substances and by varying the concentration of the solution, the liquid volume flow, the drying temperature, and the pressure applied to the nozzle. This gives us the capability to respond to almost any customer requirement and develop solutions tailored to their needs,” says Weber.
The new process for the encapsulation of active ingredients could be of interest to fertilizer manufacturers and food processing companies as well as the cosmetics and pharmaceutical industries.
The Latest on: Drug delivery
- Global Buccal Drug Delivery Systems Market 2020 Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025on March 22, 2020 at 3:56 am
Global Buccal Drug Delivery Systems Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 is a compilation of intelligent, broad research study which gives the authentic data ...
- Correction to “Effect of Hydrophobicity of Core on the Anticancer Efficiency of Micelles as Drug Delivery Carriers”on March 21, 2020 at 6:53 pm
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...
- Stay-At-Home Survival Guide: Santa Cruz Co. Food, Drug Deliveryon March 20, 2020 at 10:11 am
Food and alcohol delivery services, restaurants offering deals, free or inexpensive streaming options, pharmacy deliveries and more.
- Injectable Drug Delivery Market 2020 Demand, Current Trends, Growth Analysis, Competitor Analysis, Future Forecast 2025on March 19, 2020 at 4:39 am
New York, March 19, 2020: The Global Injectable Drug Delivery Marketis expected to exceed more than US$ 775.0 Billion by 2024 at a CAGR of 11.5% in the given forecast period. The report covers ...
- Lexaria Bio begins COVID-19 drug delivery programon March 19, 2020 at 4:20 am
Lexaria Bioscience (OTCQX:LXRP) is commencing a program, in collaboration with leading laboratories in Canada and USA, to study the benefits of its DehydraTECH drug delivery platform for enhancing ...
- Lexaria Bioscience Begins Coronavirus COVID-19 Drug Delivery Programon March 19, 2020 at 3:24 am
KELOWNA, BC / ACCESSWIRE / March 19, 2020 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery technology, announces it is commencing a program, ...
- Controlled Release Drug Delivery Market Size Worth $69.8 Billion by 2027: Grand View Research, Inc.on March 19, 2020 at 12:35 am
/PRNewswire/ -- The global controlled release drug delivery market size is estimated to reach USD 69.8 billion by 2027 registering a CAGR of 7.8% during ...
- The U.S. Diabetes Monitoring, Treatment and Drug Delivery Market (2019 to 2025) - ResearchAndMarkets.comon March 18, 2020 at 9:21 am
DUBLIN--(BUSINESS WIRE)--The "Diabetes Monitoring, Treatment and Drug Delivery Market | US | 2019-2025" report has been added to ResearchAndMarkets.com's offering. The fastest-growing segment in the U ...
- Injectable Drug Delivery Market To Reach USD 1,208.49 Billion By 2027on March 18, 2020 at 6:52 am
The Injectable Drug Delivery Market is estimated to reach USD 1,208.49 Billion by 2027, according to a new report by Reports and Data. This can be mainly associated with the growing incidences of ...
- Global Injectable Drug Delivery Market (2019 to 2027) - CAGR of 8.67% Expected During the Forecast Period - ResearchAndMarkets.comon March 18, 2020 at 3:46 am
DUBLIN--(BUSINESS WIRE)--The "Global Injectable Drug Delivery Market 2019-2027" report has been added to ResearchAndMarkets.com's offering. According to an analysis by the publisher, the global ...
via Google News and Bing News